(Q37291374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

Clinical and economic burden of antimicrobial resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

main subject

antimicrobial resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

Sara E Cosgrove

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Lisa Lockerd Maragakis

series ordinal

1

object named as

Lisa L Maragakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

751-763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

Raising standards while watching the bottom line: making a business case for infection control

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Health and economic outcomes of vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Genome and virulence determinants of high virulence community-acquired MRSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

The impact of antimicrobial resistance on health and economic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Reference group choice and antibiotic resistance outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

A chronic disease score from automated pharmacy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Health and economic impact of surgical site infections diagnosed after hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

The control of confounding by intermediate variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Excess shock and mortality in Staphylococcus aureus related to methicillin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

The distinction between cost and charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

The epidemiology and control of Acinetobacter baumannii in health care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Mortality risk factors of Acinetobacter baumannii bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.751

21 January 2018

Identifiers

DOI

10.1586/14787210.6.5.751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847410%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference